GALR3


Galactoslyceramidase 3 (GALR3): A Key Enzyme in Lysosomal Lipid Metabolism

Description

Galactosylceramidase 3 (GALR3) is an enzyme that plays a critical role in the lysosomal metabolism of glycosphingolipids, a class of lipids found in the membranes of cells. Glycosphingolipids are essential for proper cell function, but their accumulation can lead to a range of diseases. GALR3 is responsible for the degradation of galactosylceramide, a glycosphingolipid that is abundant in the myelin sheath of neurons.

Associated Diseases

Mutations in the GALR3 gene can lead to lysosomal storage disorders, including:

  • Gaucher disease: The most common lysosomal storage disorder, characterized by the accumulation of glucosylceramide in macrophages and other cells.
  • Krabbe disease: A fatal neurodegenerative disorder caused by the accumulation of psychosine in the central nervous system.
  • Metachromatic leukodystrophy: Another neurodegenerative disorder resulting from the accumulation of sulfatides in the brain and spinal cord.

Did you Know ?

One in 40,000 to 60,000 people worldwide is affected by Gaucher disease, making it the most prevalent lysosomal storage disorder.



Disclaimer: The information provided here is not exhaustive by any means. Always consult your doctor or other qualified healthcare provider with any questions you may have regarding a medical condition, procedure, or treatment, whether it is a prescription medication, over-the-counter drug, vitamin, supplement, or herbal alternative.